Inhibition of Human Telomerase by a G-Quadruplex-Interactive Compound
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVLetterNEXTInhibition of Human Telomerase by a G-Quadruplex-Interactive CompoundDaekyu Sun, Brian Thompson, Brian E. Cathers, Miguel Salazar, Sean M. Kerwin, John O. Trent, Terence C. Jenkins, Stephen Neidle, and Laurence H. HurleyView Author Information Institute for Drug Development, 14960 Omicron Drive, San Antonio, Texas 78245-3217, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712-1074, and CRC Biomolecular Structure Unit, The Institute of Cancer Research, Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom Cite this: J. Med. Chem. 1997, 40, 14, 2113–2116Publication Date (Web):July 4, 1997Publication History Received25 March 1997Published online4 July 1997Published inissue 1 July 1997https://pubs.acs.org/doi/10.1021/jm970199zhttps://doi.org/10.1021/jm970199zrapid-communicationACS PublicationsCopyright © 1997 American Chemical SocietyRequest reuse permissionsArticle Views5835Altmetric-Citations687LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-AlertscloseSupporting Info (1)»Supporting Information Supporting Information SUBJECTS:Chemical structure,G-Quadruplex,Genetics,Inhibition,Peptides and proteins Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several strategies to inhibit telomerase activity have been reported.These include peptide nucleic acids and 2¢-O-MeRNA oligonucleotides directed towards the telomerase RNA template (Herbert et al., 1999), compounds that target telomeric DNA such as cationic porphyrins or anthraquinones (Sun et al., 1997) and nucleosidic reverse transcriptase inhibitors (Strahl and Blackburn, 1996).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Sun et al., 1997
Citations
Cites
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Inhibition of telomerase by G-quartet DMA structures
Zahler, A. M., Williamson, J. R., Cech, T. R., & Prescott, D. M. (1991) · Nature · doi:10.1038/350718a0 · Cited by 1,134
Divne, C., Ståhlberg, J., Reinikainen, T., Ruohonen, L., Pettersson, G., Knowles, J. K. C., Teeri, T. T., & Jones, T. A. (1994) · Science · doi:10.1126/science.8036495 · Cited by 626
Correlating telomerase activity levels with human neuroblastoma outcomes
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W. (1995) · Nature Medicine · doi:10.1038/nm0395-249 · Cited by 611
Crystal structure of four-stranded Oxytricha telomeric DNA
Kang, C., Zhang, X., Ratliff, R., Moyzis, R., & Rich, A. (1992) · Nature · doi:10.1038/356126a0 · Cited by 555
The High-Resolution Crystal Structure of a Parallel-Stranded Guanine Tetraplex
Laughlan, G., Murchie, A. I. H., Norman, D. G., Moore, M. H., Moody, P. C. E., Lilley, D. M. J., & Luisi, B. (1994) · Science · doi:10.1126/science.8036494 · Cited by 482
Telomerase Activity in Small-Cell and Non-Small-Cell Lung Cancers
Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., & Shay, J. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.12.895 · Cited by 440
Research works printed but not linked: 10
- Telomeres, 1995, Cold Spring Harbor Press: New York
- Harley C. B., 1994, Cancer. Cold Spring Harbor Symp. Quant. Biol.
- Broccoli D., 1994, Proc. Natl. Acad. Sci. U.S.A., 92, 9086
- Rhyu M. S., 1995, J. Natl. Cancer Inst., 87, 894
- Salazar M., 1996, Biochemistry, 35, 16115
- Fox K. R., 1995, Proc. Natl. Acad. Sci. U.S.A., 92, 7891
- Haq I., 1996, J. Am. Chem. Soc., 118, 10701
- Tanious F. A., 1992, Biochemistry, 31, 11640
- Wang Y., 1992, Biochemistry, 31, 8119
- Chen Q., 1996, Proc. Natl. Acad. Sci. U.S.A., 93, 2639
Cited by
Siddiqui-Jain, A., Grand, C. L., Bearss, D. J., & Hurley, L. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182256799 · Cited by 2,238
Self-citationTargeting G-quadruplexes in gene promoters: a novel anticancer strategy?
Balasubramanian, S., Hurley, L. H., & Neidle, S. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3428 · Cited by 1,692
“One approach focused on targeting telomeric sequences that could potentially form G-quadruplexe”
BackgroundSelf-citationG‐Quartets 40 Years Later: From 5′‐GMP to Molecular Biology and Supramolecular Chemistry
Davis, J. T. (2004) · Angewandte Chemie International Edition · doi:10.1002/anie.200300589 · Cited by 1,626
G-quadruplexes and their regulatory roles in biology
Rhodes, D., & Lipps, H. J. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv862 · Cited by 1,487
DNA secondary structures: stability and function of G-quadruplex structures
Bochman, M. L., Paeschke, K., & Zakian, V. A. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3296 · Cited by 1,446
DNA and its associated processes as targets for cancer therapy
Hurley, L. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc749 · Cited by 1,349
Self-citationThe regulation and functions of DNA and RNA G-quadruplexes
Varshney, D., Spiegel, J., Zyner, K., Tannahill, D., & Balasubramanian, S. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0236-x · Cited by 1,278
The Structure and Function of DNA G-Quadruplexes
Spiegel, J., Adhikari, S., & Balasubramanian, S. (2020) · Trends in Chemistry · doi:10.1016/j.trechm.2019.07.002 · Cited by 920
“cules that sequester telomeric ends as stable, liganded G4 structures, which are thought to render telomeric ends inaccessible for telomerase-mediated extension [25].”
BackgroundPatel, D. J., Phan, A. T., & Kuryavyi, V. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm711 · Cited by 882
“This concept was first validated when it was demonstrated that 2,6-diamidodianthraquinone inhibits the activity of telomerase by interacting with and stabilizing G-quadruplex structures (211).”
BackgroundA hitchhiker's guide to G-quadruplex ligands
Monchaud, D., & Teulade-Fichou, M.-P. (2008) · Org. Biomol. Chem. · doi:10.1039/b714772b · Cited by 788
Small-molecule–induced DNA damage identifies alternative DNA structures in human genes
Rodriguez, R., Miller, K. M., Forment, J. V., Bradshaw, C. R., Nikan, M., Britton, S., Oelschlaegel, T., Xhemalce, B., Balasubramanian, S., & Jackson, S. P. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.780 · Cited by 741
“that are suitable for selective recognition by small molecule”
5'-UTR RNA G-quadruplexes: translation regulation and targeting
Bugaut, A., & Balasubramanian, S. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks068 · Cited by 642
“This has led to the proposal of a new anticancer strategy based on small molecule agents that could target and stabilize G-quadruplex structures at telomeres with a view to inhibit telomerase function and thus impart cell death (11,12).”
BackgroundTelomere maintenance as a target for anticancer drug discovery
Neidle, S., & Parkinson, G. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd793 · Cited by 624
“A study of a series of substituted anthraquinone compounds (originally developed as conventional cytotoxic agents) showed inhibition of the activity of human telomeras”
BackgroundSelf-citationBurger, A. M., Dai, F., Schultes, C. M., Reszka, A. P., Moore, M. J., Double, J. A., & Neidle, S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2910 · Cited by 587
“A small-molecule approach has been devised that targets telomeres rather than telomerase per se (19).”
BackgroundSelf-citationThe application of DNA and RNA G-quadruplexes to therapeutic medicines
Collie, G. W., & Parkinson, G. N. (2011) · Chemical Society Reviews · doi:10.1039/c1cs15067g · Cited by 589
G-quadruplex nucleic acids as therapeutic targets
Balasubramanian, S., & Neidle, S. (2009) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2009.04.637 · Cited by 586
“com this could be induced by small-molecule quadruplex stabilisation was first demonstrated using a disubstituted anthraquinone derivative [18].”
BackgroundSelf-citationQuadruplex Nucleic Acids as Novel Therapeutic Targets
Neidle, S. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01835 · Cited by 582
Self-citationTargeting telomeres and telomerase
De Cian, A., Lacroix, L., Douarre, C., Temime-Smaali, N., Trentesaux, C., Riou, J.-F., & Mergny, J.-L. (2008) · Biochimie · doi:10.1016/j.biochi.2007.07.011 · Cited by 572
Human telomeric G‐quadruplex: structures of DNA and RNA sequences
Phan, A. T. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07464.x · Cited by 538
Neidle, S. (2010) · The FEBS Journal · doi:10.1111/j.1742-4658.2009.07463.x · Cited by 545
Self-citationKim, M.-Y., Vankayalapati, H., Shin-ya, K., Wierzba, K., & Hurley, L. H. (2002) · Journal of the American Chemical Society · doi:10.1021/ja017308q · Cited by 525
Self-citationHerbert, B.-S., Pitts, A. E., Baker, S. I., Hamilton, S. E., Wright, W. E., Shay, J. W., & Corey, D. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.25.14276 · Cited by 539
Telomestatin, a Novel Telomerase Inhibitor from Streptomyces anulatus
Shin-ya, K., Wierzba, K., Matsuo, K.-I., Ohtani, T., Yamada, Y., Furihata, K., Hayakawa, Y., & Seto, H. (2001) · Journal of the American Chemical Society · doi:10.1021/ja005780q · Cited by 509
Shay, J. W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.7.677 · Cited by 509
Rodriguez, R., Müller, S., Yeoman, J. A., Trentesaux, C., Riou, J.-F., & Balasubramanian, S. (2008) · Journal of the American Chemical Society · doi:10.1021/ja805615w · Cited by 517
Structure-based design of selective and potent G quadruplex-mediated telomerase inhibitors
Read, M., Harrison, R. J., Romagnoli, B., Tanious, F. A., Gowan, S. H., Reszka, A. P., Wilson, W. D., Kelland, L. R., & Neidle, S. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081560598 · Cited by 493
Self-citationInteraction of Metal Complexes with G‐Quadruplex DNA
Georgiades, S. N., Abd Karim, N. H., Suntharalingam, K., & Vilar, R. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200906363 · Cited by 486
G-quadruplex DNA: a potential target for anti-cancer drug design
Han, H., & Hurley, L. H. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01457-7 · Cited by 487
Self-citationG‐Quadruplexes: Targets in Anticancer Drug Design
Ou, T., Lu, Y., Tan, J., Huang, Z., Wong, K., & Gu, L. (2008) · ChemMedChem · doi:10.1002/cmdc.200700300 · Cited by 482
Lim, K. W., Amrane, S., Bouaziz, S., Xu, W., Mu, Y., Patel, D. J., Luu, K. N., & Phan, A. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja807503g · Cited by 471
Quadruplex nucleic acids as targets for anticancer therapeutics
Neidle, S. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0041 · Cited by 461
Self-citationThe structure of telomeric DNA
Neidle, S., & Parkinson, G. N. (2003) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(03)00072-1 · Cited by 450
Self-citationG-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy
Ruggiero, E., & Richter, S. N. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky187 · Cited by 440
“Read and colleagues demonstrated that the acridine core was more active than the previously developed anthraquinone core (96,97), because of the presence of a nitrogen atom in the heterocyclic scaffold that could be protonated at physiological conditions.”
BackgroundThe structures of quadruplex nucleic acids and their drug complexes
Neidle, S. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.04.001 · Cited by 433
Self-citationA highly selective telomerase inhibitor limiting human cancer cell proliferation
Damm, K., Hemmann, U., Garin‐Chesa, P., Hauel, N., Kauffmann, I., Priepke, H., Niestroj, C., Daiber, C., Enenkel, B., Guilliard, B., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6958 · Cited by 422
Cell senescence and telomere shortening induced by a new series of specific G-quadruplex DNA ligands
Riou, J. F., Guittat, L., Mailliet, P., Laoui, A., Renou, E., Petitgenet, O., Mégnin-Chanet, F., Hélène, C., & Mergny, J. L. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052698099 · Cited by 394
Fluorescence-based melting assays for studying quadruplex ligands
DECIAN, A., GUITTAT, L., KAISER, M., SACCA, B., AMRANE, S., BOURDONCLE, A., ALBERTI, P., TEULADEFICHOU, M., LACROIX, L., & MERGNY, J. (2007) · Methods · doi:10.1016/j.ymeth.2006.10.004 · Cited by 381
G-quadruplex DNA: A target for drug design
Mergny, J.-L., & Hélène, C. (1998) · Nature Medicine · doi:10.1038/3949 · Cited by 384
Structure of Human Telomeric DNA in Crowded Solution
Heddi, B., & Phan, A. T. (2011) · Journal of the American Chemical Society · doi:10.1021/ja200786q · Cited by 366
Grand, C. L., Han, H., Muñoz, R. M., Weitman, S., Hoff, D. D. V., Hurley, L. H., & Bearss, D. J. (2002) · PubMed · Cited by 368
Self-citationNatural and pharmacological regulation of telomerase
Mergny, J.-L. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.4.839 · Cited by 352
Reed, J. E., Arnal, A. A., Neidle, S., & Vilar, R. (2006) · Journal of the American Chemical Society · doi:10.1021/ja058509n · Cited by 338
Self-citationExistence and consequences of G-quadruplex structures in DNA
Murat, P., & Balasubramanian, S. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.10.012 · Cited by 346
“Notable examples of chemical biological studies include the small molecule inhibition of telomerase action via G-quadruplex stabilization [11], and also transcriptional suppression of MYC by a G-quadruplex ligand [12].”
BackgroundRezler, E. M., Seenisamy, J., Bashyam, S., Kim, M.-Y., White, E., Wilson, W. D., & Hurley, L. H. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0505088 · Cited by 338
Self-citationStructural Basis of DNA Quadruplex Recognition by an Acridine Drug
Campbell, N. H., Parkinson, G. N., Reszka, A. P., & Neidle, S. (2008) · Journal of the American Chemical Society · doi:10.1021/ja8016973 · Cited by 326
Self-citationMechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug Candidate
Pascolo, E., Wenz, C., Lingner, J., Hauel, N., Priepke, H., Kauffmann, I., Garin-Chesa, P., Rettig, W. J., Damm, K., & Schnapp, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201266200 · Cited by 326
Telomerase: A target for cancer therapeutics
Shay, J. W., & Wright, W. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00159-9 · Cited by 339
“, 1999)], telomerase-specific phosphorylation inhibitors, blocking telomerase accessibility [Gquadraplex stabilizers (Riou et al., 2002; Gowan et al., 2002; Sun et al., 1997; Read et al., 1999)], hammerhead ribozymes directed against hTR [Yokoyama et al.”
BackgroundIdentification and Characterization of Nucleolin as a c-myc G-quadruplex-binding Protein
González, V., Guo, K., Hurley, L., & Sun, D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018028 · Cited by 321
Self-citationStructural Insights into G-Quadruplexes: Towards New Anticancer Drugs
Yang, D., & Okamoto, K. (2010) · Future Medicinal Chemistry · doi:10.4155/fmc.09.172 · Cited by 322
Bulges in G-Quadruplexes: Broadening the Definition of G-Quadruplex-Forming Sequences
Mukundan, V. T., & Phan, A. T. (2013) · Journal of the American Chemical Society · doi:10.1021/ja310251r · Cited by 311
Seenisamy, J., Bashyam, S., Gokhale, V., Vankayalapati, H., Sun, D., Siddiqui-Jain, A., Streiner, N., Shin-ya, K., White, E., Wilson, W. D., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja0444482 · Cited by 319
Self-citationPhysiological relevance of telomeric G‐quadruplex formation: a potential drug target
Oganesian, L., & Bryan, T. M. (2007) · BioEssays · doi:10.1002/bies.20523 · Cited by 309
“The first direct demonstration of a synthetic G-quadruplex interactive compound (2,6-diamidoanthraquinone or BSU1051) inhibiting human telomerase in vitro was reported almost a decade ago.((70)) The inhibition became manifest only when sufficient telomeric repeatswere assembled by telomerase extension of the DNA prime…”
BackgroundMethodKinetics of tetramolecular quadruplexes
Mergny, J.-L. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki148 · Cited by 311
Gowan, S. M., Harrison, J. R., Patterson, L., Valenti, M., Read, M. A., Neidle, S., & Kelland, L. R. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12212-2 · Cited by 303
Self-citationTargeting MYC Expression through G-Quadruplexes
Brooks, T. A., & Hurley, L. H. (2010) · Genes & Cancer · doi:10.1177/1947601910377493 · Cited by 301
Self-citationReevaluation of telomerase inhibition by quadruplex ligands and their mechanisms of action
De Cian, A., Cristofari, G., Reichenbach, P., De Lemos, E., Monchaud, D., Teulade-Fichou, M.-P., Shin-ya, K., Lacroix, L., Lingner, J., & Mergny, J.-L. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0707365104 · Cited by 292
Telomerase inhibitors based on quadruplex ligands selected by a fluorescence assay
Mergny, J.-L., Lacroix, L., Teulade-Fichou, M.-P., Hounsou, C., Guittat, L., Hoarau, M., Arimondo, P. B., Vigneron, J.-P., Lehn, J.-M., Riou, J.-F., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051620698 · Cited by 291
Ma, D.-L., Che, C.-M., & Yan, S.-C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja806045x · Cited by 289
Palumbo, S. L., Ebbinghaus, S. W., & Hurley, L. H. (2009) · Journal of the American Chemical Society · doi:10.1021/ja902281d · Cited by 279
Self-citationBiological potential of carbazole derivatives
Głuszyńska, A. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2015.02.059 · Cited by 280
Recent Progress of Targeted G-Quadruplex-Preferred Ligands Toward Cancer Therapy
Asamitsu, S., Obata, S., Yu, Z., Bando, T., & Sugiyama, H. (2019) · Molecules · doi:10.3390/molecules24030429 · Cited by 275
“in this region is first assumed in the human genome [36,37].”
BackgroundInfluentialStructure of a G-quadruplex–Ligand Complex
Haider, S. M., Parkinson, G. N., & Neidle, S. (2003) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)01354-2 · Cited by 275
Self-citationRegulation of the human catalytic subunit of telomerase (hTERT)
Daniel, M., Peek, G. W., & Tollefsbol, T. O. (2012) · Gene · doi:10.1016/j.gene.2012.01.095 · Cited by 266
G-quadruplex DNA targeted metal complexes acting as potential anticancer drugs
Cao, Q., Li, Y., Freisinger, E., Qin, P. Z., Sigel, R. K. O., & Mao, Z.-W. (2017) · Inorganic Chemistry Frontiers · doi:10.1039/c6qi00300a · Cited by 265
Kelland, L. R. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.11.024 · Cited by 252
Martadinata, H., & Phan, A. T. (2009) · Journal of the American Chemical Society · doi:10.1021/ja806592z · Cited by 239
Fluorescence Resonance Energy Transfer as a Probe for G-Quartet Formation by a Telomeric Repeat
Mergny, J., & Maurizot, J. (2001) · ChemBioChem · doi:10.1002/1439-7633(20010202)2:2<99::aid-cbic99>3.0.co;2-3 · Cited by 245
Gowan, S. M., Heald, R., Stevens, M. F. G., & Kelland, L. R. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12507-2 · Cited by 230
“Classes of G-quadruplex inhibitors described to date by us include the first reported small-molecule telomerase inhibitors, disubstituted anthraquinones (Sun et al., 1997; Perry et al., 1998), fluorenones (Perry et al.”
A DNA polymerase stop assay for G-quadruplex-interactive compounds
Han, H., Hurley, L. H., & Salazar, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.2.537 · Cited by 235
Self-citationStructural Basis for Telomeric G-Quadruplex Targeting by Naphthalene Diimide Ligands
Collie, G. W., Promontorio, R., Hampel, S. M., Micco, M., Neidle, S., & Parkinson, G. N. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2102423 · Cited by 232
Self-citation40 Jahre G‐Quartetts: von 5′‐GMP zur Molekularbiologie und Supramolekularen Chemie
Davis, J. T. (2004) · Angewandte Chemie · doi:10.1002/ange.200300589 · Cited by 230
Campbell, N. H., Karim, N. H. A., Parkinson, G. N., Gunaratnam, M., Petrucci, V., Todd, A. K., Vilar, R., & Neidle, S. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm201140v · Cited by 220
Self-citationKoeppel, F. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.5.1087 · Cited by 221
Tauchi, T., Shin-ya, K., Sashida, G., Sumi, M., Okabe, S., Ohyashiki, J. H., & Ohyashiki, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209577 · Cited by 218
“Ionic conditions that favor quadruplex formation have been shown to inhibit telomerase, and small molecules that stabilize or promote formation of quadruplexes also have shown inhibitory activity (Zahler et al., 1991; Sun et al., 1997; Wheelhouse et al., 1998; Izbicka et al., 1999).”
BackgroundG-quadruplexes as targets for drug design
Hurley, L. H., Wheelhouse, R. T., Sun, D., Kerwin, S. M., Salazar, M., Fedoroff, O. Y., Han, F. X., Han, H., Izbicka, E., & Von Hoff, D. D. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00068-6 · Cited by 217
Self-citationIntercalative G-Tetraplex Stabilization of Telomeric DNA by a Cationic Porphyrin1
Haq, I., Trent, J. O., Chowdhry, B. Z., & Jenkins, T. C. (1999) · Journal of the American Chemical Society · doi:10.1021/ja981554t · Cited by 221
Self-citationMolecular Dynamics and Principal Components Analysis of Human Telomeric Quadruplex Multimers
Haider, S., Parkinson, G. N., & Neidle, S. (2008) · Biophysical Journal · doi:10.1529/biophysj.107.120501 · Cited by 211
“It has also been established experimentally that small molecule-induced stabilization of G-quadruplexes can inhibit the enzyme telomerase, leading to telomere shortening and cell death in neoplastic cells (6,7).”
BackgroundSelf-citationGomez, D., Wenner, T., Brassart, B., Douarre, C., O'Donohue, M.-F., El Khoury, V., Shin-ya, K., Morjani, H., Trentesaux, C., & Riou, J.-F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m605828200 · Cited by 206
RNA G-quadruplexes (rG4s): genomics and biological functions
Lyu, K., Chow, E. Y.-C., Mou, X., Chan, T.-F., & Kwok, C. K. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab187 · Cited by 220
“Similarly, small molecules that target G4 can stabilize the structure, and the first G4-targeting compound was developed to inhibit the telomerase-mediated telomere extension (19).”
BackgroundTauchi, T., Shin-ya, K., Sashida, G., Sumi, M., Nakajima, A., Shimamoto, T., Ohyashiki, J. H., & Ohyashiki, K. (2003) · Oncogene · doi:10.1038/sj.onc.1206833 · Cited by 206
“…Group All rights reserved 0950-9232/03 $25.00 www.nature.com/onc telomerase (Zahler et al., 1991), while small molecules that stabilize or promote the formation of quadruplex also show inhibitory activity (Sun et al., 1997; Wheelhouse et al., 1998; Izbicka et al., 1999; Perry and Jenkins, 1999).”
BackgroundInfluentialG-quadruplexes as therapeutic targets
Neidle, S., & Read, M. A. (2000) · Biopolymers · doi:10.1002/1097-0282(2000)56:3<195::aid-bip10009>3.0.co;2-5 · Cited by 206
Self-citationWhite, E. W., Tanious, F., Ismail, M. A., Reszka, A. P., Neidle, S., Boykin, D. W., & Wilson, W. D. (2007) · Biophysical Chemistry · doi:10.1016/j.bpc.2006.06.006 · Cited by 199
Self-citationInduction of Duplex to G-quadruplex Transition in the c-myc Promoter Region by a Small Molecule
Rangan, A., Fedoroff, O. Y., & Hurley, L. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m005962200 · Cited by 203
Self-citationPiazza, A., Boulé, J.-B., Lopes, J., Mingo, K., Largy, E., Teulade-Fichou, M.-P., & Nicolas, A. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq136 · Cited by 184
“The presence of G4-forming sequences at human telomeres and the fact that the first generation of G4-binding ligands were able to inhibit telomerase (16) have largely contributed to make G4 the archetypal higher order nucleic acid structure for the design of selectively targeting ligands in the presence of duplex DNA.”
G-Quadruplexes at Telomeres: Friend or Foe?
Bryan, T. M. (2020) · Molecules · doi:10.3390/molecules25163686 · Cited by 187
Micco, M., Collie, G. W., Dale, A. G., Ohnmacht, S. A., Pazitna, I., Gunaratnam, M., Reszka, A. P., & Neidle, S. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301899y · Cited by 185
Self-citationCoexistence of Two Distinct G-Quadruplex Conformations in the hTERT Promoter
Lim, K. W., Lacroix, L., Yue, D. J. E., Lim, J. K. C., Lim, J. M. W., & Phan, A. T. (2010) · Journal of the American Chemical Society · doi:10.1021/ja101252n · Cited by 185
Small-molecule quadruplex-targeted drug discovery
Ohnmacht, S. A., & Neidle, S. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.04.029 · Cited by 176
Self-citationParkinson, G. N., Cuenca, F., & Neidle, S. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.06.022 · Cited by 175
Self-citationChen, Z.-F., Qin, Q.-P., Qin, J.-L., Liu, Y.-C., Huang, K.-B., Li, Y.-L., Meng, T., Zhang, G.-H., Peng, Y., Luo, X.-J., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/jm5012484 · Cited by 174
G-quadruplex conformation and dynamics are determined by loop length and sequence
Tippana, R., Xiao, W., & Myong, S. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku464 · Cited by 169
White, L. K., Wright, W. E., & Shay, J. W. (2001) · Trends in Biotechnology · doi:10.1016/s0167-7799(00)01541-9 · Cited by 171
Targeting G-quadruplex structures with extrinsic fluorogenic dyes: promising fluorescence sensors
Bhasikuttan, A. C., & Mohanty, J. (2015) · Chemical Communications · doi:10.1039/c4cc10030a · Cited by 169
G4LDB: a database for discovering and studying G-quadruplex ligands
Li, Q., Xiang, J.-F., Yang, Q.-F., Sun, H.-X., Guan, A.-J., & Tang, Y.-L. (2013) · Nucleic Acids Research · doi:10.1093/nar/gks1101 · Cited by 164
“The stability of G-quadruplex structures potentially plays an important role in telomere maintenance (5,6) and in the regulation of gene expression (7,8).”
BackgroundLigand Design to Acquire Specificity to Intended G‐Quadruplex Structures
Asamitsu, S., Bando, T., & Sugiyama, H. (2019) · Chemistry – A European Journal · doi:10.1002/chem.201802691 · Cited by 164
Human telomerase inhibition by substituted acridine derivatives
Harrison, R. J., Gowan, S. M., Kelland, L. R., & Neidle, S. (1999) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(99)00394-7 · Cited by 161
Self-citationIncles, C. M., Schultes, C. M., Kempski, H., Koehler, H., Kelland, L. R., & Neidle, S. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1201.3.10 · Cited by 158
“This interferes with the initial step in the elongation of telomeric DNA by telomerase (10) because effective recognition of the telomere overhang by the RNA template domain of telomerase requires its 3V end to be single stranded.”
BackgroundSelf-citationMüller, S., Sanders, D. A., Antonio, M. D., Matsis, S., Riou, J., Rodriguez, R., & Balasubramanian, S. (2012) · Organic & Biomolecular Chemistry · doi:10.1039/c2ob25830g · Cited by 161
1,4- and 2,6-Disubstituted Amidoanthracene-9,10-dione Derivatives as Inhibitors of Human Telomerase
Perry, P. J., Gowan, S. M., Reszka, A. P., Polucci, P., Jenkins, T. C., Kèlland, L. R., & Neidle, S. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9801105 · Cited by 171
Self-citationChen, L., Dickerhoff, J., Sakai, S., & Yang, D. (2022) · Accounts of Chemical Research · doi:10.1021/acs.accounts.2c00337 · Cited by 165
Metadata
- Authors
- Sun, D., Thompson, B., Cathers, B. E., Salazar, M., Kerwin, S. M., Trent, J. O., Jenkins, T. C., Neidle, S., & Hurley, L. H.
- Affiliations
- The University of Texas at Austin (US)
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1997-07-01
- Volume
- 40
- Issue
- 14
- Pages
- 2113-2116
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2025811126
- Semantic Scholar
- 67b8d8f99c37d9233c470812b601e6637423725f
- Cited by
- 794
- References
- 21
- Citations by year
- 2026: 12 · 2025: 10 · 2024: 29 · 2023: 19 · 2022: 46 · 2021: 46 · 2020: 35 · 2019: 27 · 2018: 27 · 2017: 20 · 2016: 36 · 2015: 42 · 2014: 38 · 2013: 33 · 2012: 39
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institutes of Health (7u19ca067760-05)
- National Cancer Institute (CA-67760, CA 49751)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Keywords
- G-quadruplex, human telomerase reverse transcriptase, telomere replication, anticancer agents
- MeSH terms
- Anthraquinones, Base Sequence, DNA, Enzyme Inhibitors, Humans, Nucleic Acid Conformation, Nucleic Acid Denaturation, Oligodeoxyribonucleotides, Molecular Structure, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.